Jazz Pharma director Bruce C. Cozadd disposes of USD 1.79 million in ordinary shares
JAZZ•Director share sales
- Jazz Pharmaceuticals director Bruce C. Cozadd cut his stake via sales on Aug. 31 and Sept. 1.
- Total disposed: 7,219 ordinary shares; prices ranged from $241.39 to $250.13.
- Beneficial ownership fell to 351,875 ordinary shares following the transactions.
